Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBaylor Research Institute
About this trial
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
Eligibility criteria
Qualifiers
All individuals aged 18 years and older
Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years
Individual is able to understand and sign the informed consent form
Disqualifiers
Significant documented anemia (hemoglobin <8 g/dL)
Blood transfusions within past 3 weeks
Active cancer (non-skin cancers)
Enrollment against doctor recommendation
Trial design
Treatments tested in this trial
- Patient Biospecimen Registry (observational and blood sampling)
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov